Sartorius Stedim Biotech S.A.

Sartorius Stedim Biotech S.A. is a leading international partner to the biopharmaceutical industry, headquartered in Aubagne, France, and operating as a subsidiary of Sartorius AG with approximately 9,900 employees across more than 30 countries. The company offers a comprehensive portfolio of products and services covering virtually all major steps in biopharmaceutical development and manufacturing, including cell culture technologies, single-use bioreactors, filtration and purification systems, fluid management solutions, and specialized devices for cell and gene therapy applications. As a pure-play bioprocessing company listed on Euronext Paris, Sartorius Stedim Biotech also provides value-added services such as cell cultivation, fermentation, and data analytics software to optimize bioprocess workflows for a diverse clientele spanning pharmaceutical, food, and chemical manufacturers as well as research institutions. In 2024, the company generated sales revenue of approximately 2.8 billion euros, reflecting its entrenched position as a critical technology partner in the fast-growing biopharmaceutical sector.